THSB2 as a prognostic biomarker for patients diagnosed with metastatic pancreatic ductal adenocarcinoma.
Gimotty PA, Till JE, Udgata S, Takenaka N, Yee SS, LaRiviere MJ, O'Hara MH, Reiss KA, O'Dwyer P, Katona BW, Herman D, Carpenter EL, Zaret KS.
Gimotty PA, et al. Among authors: udgata s.
Oncotarget. 2021 Oct 26;12(22):2266-2272. doi: 10.18632/oncotarget.28099. eCollection 2021 Oct 26.
Oncotarget. 2021.
PMID: 34733417
Free PMC article.